India has played a crucial role in making essential medicines available and affordable for patients in the developing world through generic drugs. This has been possible by linking India’s patent policies and laws to public interest. Similarly, policies that align public funded R&D in India with public health have the potential to provide incentives to the development of medical technologies (vaccines, diagnostics and medicines) crucial for treating neglected diseases like...

The government needs to allocate more funds for public health. The mismatch between the declared objective of universal healthcare through the public health system and the actual level of expenditure remains serious.  One of the three most important planks on which Barak Obama won the U.S. presidential election was the country’s healthcare system, which he promised to fix. Indeed, the most important legislative measure initiated by Mr. Obama so far...

Endorsing or participating in private studies on efficacy of drugs and accepting any kind of hospitality from pharma companies might be a thing of the past for doctors with the Medical Council of India coming out with a fresh code of conduct for medical practitioners. The MCI through an amendment to the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulation 2002” has brought out the code of conduct which includes...

The recent high-pressure tactics to introduce genetically engineered food crops in India are another rude reminder that Western agribusiness companies have a deeprooted strategy to obtain a stranglehold on India’s food and agriculture system. In a review of recent trends titled ‘Food Without Choice’ (The Tribune, November 1) Prof Pushpa M. Bhargava (who was nominated by the Supreme Court in the Genetic Engineering Approval Committee to protect safety concerns), an internationally...

Drug companies in India will be prohibited from handing out cash or gifts or stand-alone entertainment to doctors under a code of ethics proposed by industry associations to govern the marketing of medicines. But the code has run into rough weather even before it has been adopted, with at least two industry associations disassociating themselves from the document, tabled at a meeting called today by the government’s department of pharmaceuticals. The two...